Literature DB >> 18383161

Protamine usage following implantation of drug-eluting stents: a word of caution.

John Cosgrave1, Asif Qasim, Azeem Latib, Tiziana C Aranzulla, Antonio Colombo.   

Abstract

The treatment of hemorrhagic complications of percutaneous interventions with protamine is an accepted practice. Concerns exist about the increased thrombo-genicity of drug-eluting stents. We report two cases of acute stent thrombosis following drug-eluting stent implantation related to protamine administration. 2008 Wiley-Liss, Inc.

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18383161     DOI： 10.1002/ccd.21439

Source DB:  PubMed          Journal:  Catheter Cardiovasc Interv        ISSN： 1522-1946            Impact factor:   2.692


  3 in total

1.  Multiple preoperative and intraoperative factors predict early fistula thrombosis in the Hemodialysis Fistula Maturation Study.

Authors:  Alik Farber; Peter B Imrey; Thomas S Huber; James M Kaufman; Larry W Kraiss; Brett Larive; Liang Li; Harold I Feldman
Journal:  J Vasc Surg       Date:  2016-01       Impact factor: 4.268

2.  Short-Term Safety and Efficacy of Femoral Vascular Closure after Percutaneous Coronary Intervention with Combination of the Boomerang(TM) Device and Intravenous Protamine Sulfate.

Authors:  Ching-Pei Chen; Huang-Kai Huang; Chien-Hsun Hsia; Yung-Ming Chang; Lee-Shin Lin; Cheng-Liang Lee
Journal:  Acta Cardiol Sin       Date:  2013-11       Impact factor: 2.672

3.  Use of protamine sulfate during transfemoral transcatheter aortic valve implantation - a preliminary assessment of administration rate and impact on complications.

Authors:  Karol Zbroński; Kajetan Grodecki; Roksana Gozdowska; Szymon Jędrzejczyk; Ewa Ostrowska; Julia Wysińska; Bartosz Rymuza; Piotr Scisło; Radosław Wilimski; Janusz Kochman; Krzysztof J Filipiak; Grzegorz Opolski; Zenon Huczek
Journal:  Postepy Kardiol Interwencyjnej       Date:  2020-10-02       Impact factor: 1.426
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.